The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy When will the FDA reclassify BPC 157 to Category 1 Octagon AI HIMS: Regulatory Arbitrage and the Future of Personalized Medicine FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting FDA Peptide Update: Category 2 Removals Explained
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
fda 503a bulks list category 2 bpc-157 Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides